Hicks Holdings LLC, a Dallas-based private investment enterprise, has acquired a 40 percent stake in SafeMed, a San Diego-based provider of clinical decision support systems. Financial terms of the agreement were not disclosed
According to SafeMed, it currently offers three products:
- SafeMed Phama identifies prescription drug alternatives, ranking them by safety, efficacy and affordability based on patient-specific data in conjunction with insurer business rules.
- SafeMed Imaginghelps identify and rank diagnostic imaging tests for a specific patient, and provides an authorization and approval process.
- SafeMed Quality analyzes patient data against Class I quality guidelines in real time to help identify and resolve gaps in care.
According to Hicks, the investment will enable SafeMed to accelerate the continuing implementation of its business strategy.
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.